|
1
|
Razavi-Azarkhiavi K, Iranshahy M, Sahebkar
A, Shirani K and Karimi G: The protective role of phenolic
compounds against doxorubicin-induced cardiotoxicity: A
comprehensive review. Nutr Cancer. 68:892–917. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Swain SM, Whaley FS and Ewer MS:
Congestive heart failure in patients treated with doxorubicin: A
retrospective analysis of three trials. Cancer. 97:2869–2879. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ganame J, Claus P, Uyttebroeck A, Renard
M, D'hooge J, Bijnens B, Sutherland GR, Eyskens B and Mertens L:
Myocardial dysfunction late after low-dose anthracycline treatment
in asymptomatic pediatric patients. J Am Soc Echocardiogr.
20:1351–1358. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tebbi CK, London WB, Friedman D, Villaluna
D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A
and Schwartz CL: Dexrazoxane-associated risk for acute myeloid
leukemia/myelodysplastic syndrome and other secondary malignancies
in pediatric Hodgkin's disease. J Clin Oncol. 25:493–500. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shaikh AY and Shih JA:
Chemotherapy-induced cardiotoxicity. Curr Heart Fail Rep.
9:117–127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iqbal M, Dubey K, Anwer T, Ashish A and
Pillai KK: Protective effects of telmisartan against acute
doxorubicin-induced cardiotoxicity in rats. Pharmacol Rep.
60:382–390. 2008.PubMed/NCBI
|
|
7
|
Zong WN, Yang XH, Chen XM, Huang HJ, Zheng
HJ, Qin XY, Yong YH, Cao K, Huang J and Lu XZ: Regulation of
angiotensin-(1–7) and angiotensin II type 1 receptor by telmisartan
and losartan in adriamycin-induced rat heart failure. Acta
Pharmacol Sin. 32:1345–1350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Angsutararux P, Luanpitpong S and
Issaragrisil S: Chemotherapy-induced cardiotoxicity: Overview of
the roles of oxidative stress. Oxid Med Cell Longev.
2015:7956022015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang SA, Lim BK, Lee YJ, Hong MK, Choi JO
and Jeon ES: A Novel Angiotensin Type I receptor antagonist,
fimasartan, prevents doxorubicin-induced cardiotoxicity in rats. J
Korean Med Sci. 30:559–568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Manohar P and Pina IL: Therapeutic role of
angiotensin II receptor blockers in the treatment of heart failure.
Mayo Clin Proc. 78:334–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakamae H, Tsumura K, Terada Y, Nakane T,
Nakamae M, Ohta K, Yamane T and Hino M: Notable effects of
angiotensin II receptor blocker, valsartan, on acute cardiotoxic
changes after standard chemotherapy with cyclophosphamide,
doxorubicin, vincristine, and prednisolone. Cancer. 104:2492–2498.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakr HF, Abbas AM and Elsamanoudy AZ:
Effect of valsartan on cardiac senescence and apoptosis in a rat
model of cardiotoxicity. Can J Physiol Pharmacol. 94:588–598. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen L, Yan KP, Liu XC, Wang W, Li C, Li M
and Qiu CG: Valsartan regulates TGF-β/Smads and TGF-β/p38 pathways
through IncRNA CHRF to improve doxorubicin-induced heart failure.
Arch Pharm Res. 41:101–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hafstad AD, Nabeebaccus AA and Shah AM:
Novel aspects of ROS signalling in heart failure. Basic Res
Cardiol. 108:3592013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dietl A and Maack C: Targeting
mitochondrial calcium handling and reactive oxygen species in heart
failure. Curr Heart Fail Rep. 14:338–349. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meitzler JL, Antony S, Wu Y, Juhasz A, Liu
H, Jiang G, Lu J, Roy K and Doroshow JH: NADPH oxidases: A
perspective on reactive oxygen species production in tumor biology.
Antioxid Redox Signal. 20:2873–2889. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bedard K and Krause KH: The NOX family of
ROS-generating NADPH oxidases: Physiology and pathophysiology.
Physiol Rev. 87:245–313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsutsui H, Kinugawa S and Matsushima S:
Oxidative stress and heart failure. Am J Physiol Heart Circ
Physiol. 301:H2181–H2190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao QD, Viswanadhapalli S, Williams P,
Shi Q, Tan C, Yi X, Bhandari B and Abboud HE: NADPH oxidase 4
induces cardiac fibrosis and hypertrophy through activating
Akt/mTOR and NFκB signaling pathways. Circulation. 131:643–655.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ruzicka M, Yuan B, Harmsen E and Leenen
FH: The renin-angiotensin system and volume overload-induced
cardiac hypertrophy in rats. Effects of angiotensin converting
enzyme inhibitor versus angiotensin II receptor blocker.
Circulation. 87:921–930. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bendall JK, Cave AC, Heymes C, Gall N and
Shah AM: Pivotal role of a gp91(phox)-containing NADPH oxidase in
angiotensin II-induced cardiac hypertrophy in mice. Circulation.
105:293–296. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murdoch CE, Zhang M, Cave AC and Shah AM:
NADPH oxidase-dependent redox signalling in cardiac hypertrophy,
remodelling and failure. Cardiovasc Res. 71:208–215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seddon M, Looi YH and Shah AM: Oxidative
stress and redox signalling in cardiac hypertrophy and heart
failure. Heart. 93:903–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Watson LE, Sheth M, Denyer RF and Dostal
DE: Baseline echocardiographic values for adult male rats. J Am Soc
Echocardiogr. 17:161–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barauna VG, Rosa KT, Irigoyen MC and de
Oliveira EM: Effects of resistance training on ventricular function
and hypertrophy in a rat model. Clin Med Res. 5:114–120. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu HN, Wang HR, Cheng D, Pei ZW, Zhu N
and Yu Q: Potential role of a disintegrin and metalloproteinase-17
(ADAM17) in age-associated ventricular remodeling of rats. RSC
Advances. 9:14321–14330. 2019. View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ye L, Haider HKH, Jiang S, Ge R, Law PK
and Sim EK: In vitro functional assessment of human skeletal
myoblasts after transduction with adenoviral bicistronic vector
carrying human VEGF165 and angiopoietin-1. J Heart Lung Transplant.
24:1393–1402. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie F, Wu D, Huang SF, Cao JG, Li HN, He
L, Liu MQ, Li LF and Chen LX: The endoplasmic reticulum
stress-autophagy pathway is involved in apelin-13-induced
cardiomyocyte hypertrophy in vitro. Acta Pharmacol Sin.
38:1589–1600. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang YL, Zhao F, Luo CC, Zhang X, Si Y,
Sun Z, Zhang L, Li QZ and Gao XJ: SOCS3-mediated blockade reveals
major contribution of JAK2/STAT5 signaling pathway to lactation and
proliferation of dairy cow mammary epithelial cells in vitro.
Molecules. 18:12987–13002. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Priya LB, Baskaran R, Huang CY and Padma
VV: Neferine ameliorates cardiomyoblast apoptosis induced by
doxorubicin: Possible role in modulating NADPH oxidase/ROS-mediated
NFkB redox signaling cascade. Sci Rep. 7:122832017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao J, Chen T, Zhao D, Zheng J and Liu Z:
Ginkgolide B Exerts Cardioprotective properties against
doxorubicin-induced cardiotoxicity by regulating reactive oxygen
species, Akt and calcium signaling pathways in vitro and in vivo.
PLoS One. 11:e01682192016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu Q, Li Q, Na R, Li X, Liu B, Meng L,
Liutong H, Fang W, Zhu N and Zheng X: Impact of repeated
intravenous bone marrow mesenchymal stem cells infusion on
myocardial collagen network remodeling in a rat model of
doxorubicin-induced dilated cardiomyopathy. Mol Cell Biochem.
387:279–285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bakhtiari E, Hosseini A and Mousavi SH:
Protective effect of Hibiscus sabdariffa against serum/glucose
deprivation-induced PC12 cells injury. Avicenna J Phytomed.
5:231–237. 2015.PubMed/NCBI
|
|
35
|
Huang CY, Chen JY, Kuo CH, Pai PY, Ho TJ,
Chen TS, Tsai FJ, Padma VV, Kuo WW, Huang CY, et al: Mitochondrial
ROS-induced ERK1/2 activation and HSF2-mediated AT1 R
upregulation are required for doxorubicin-induced cardiotoxicity. J
Cell Physiol. 233:463–475. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ibrahim MA, Ashour OM, Ibrahim YF,
El-Bitar HI, Gomaa W and Abdel-Rahim SR: Angiotensin-converting
enzyme inhibition and angiotensin AT(1)-receptor antagonism equally
improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
Pharmacol Res. 60:373–381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Khosravi M, Poursaleh A, Ghasempour G,
Farhad S and Najafi M: The effects of oxidative stress on the
development of atherosclerosis. Biol Chem. 400:711–732. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu J, Saleh MA, Kirabo A, Itani HA,
Montaniel KR, Xiao L, Chen W, Mernaugh RL, Cai H, Bernstein KE, et
al: Immune activation caused by vascular oxidation promotes
fibrosis and hypertension. J Clin Invest. 126:50–67. 2016.
View Article : Google Scholar : PubMed/NCBI
|
